A new study examines pregnancy outcomes among women using stimulants or atomoxetine during pregnancy, finding modest increases in some complications with stimulant use while highlighting important limitations of observational data.
A growing body of literature supports the reproductive safety of stimulants in pregnant women and suggests that not treating may have negative consequences for the mother and her child.
This preliminary study demonstrates the potential benefits of increasing the dosage of psychostimulant medication premenstrually in women with ADHD who experience premenstrual worsening of ADHD and mood symptoms.
To better care for pregnant and postpartum mothers with ADHD, clinicians should understand the unique facets of ADHD in women, how symptoms change during pregnancy and the postpartum period, and how to help new parents make decisions around medication use and ADHD symptom management.
ADHD is an important risk factor for both depression and anxiety disorders in the postpartum period and should be considered in the post-pregnancy maternal care.
Prenatal exposure to benzodiazepines and Z-hypnotics was not associated with increased risk of ADHD in exposed children.
In childhood, ADHD is clearly more common in boys than in girls; however, in adult samples, the sex differences in prevalence are mush smaller. There is also increasing recognition that girls and women may present [...]
While for some adults, attention-deficit/hyperactivity disorder (ADHD) is relatively mild and, with effective treatment, does not have a significant impact on overall functioning or quality of life. However, it is noteworthy that the majority of [...]
We continue to see an increasing number of women with attention-deficit/hyperactivity disorder (ADHD) who are either pregnant or planning to conceive. While we have considerable data to indicate that women with mood and anxiety [...]
According to a report published by the CDC in Morbidity and Mortality Weekly Report (MMWR), the use of stimulant medications for the treatment of attention-deficit/hyperactivity disorder (ADHD)Â by reproductive-age women is on the rise. In [...]
